Accessibility Menu
 
Exelixis logo

Exelixis

(NASDAQ) EXEL

Current Price$43.87
Market Cap$11.40B
Since IPO (2000)+189%
5 Year+90%
1 Year+18%
1 Month+8%

Exelixis Financials at a Glance

Market Cap

$11.40B

Revenue (TTM)

$2.32B

Net Income (TTM)

$782.57M

EPS (TTM)

$2.78

P/E Ratio

15.76

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$43.87

Volume

55,362

Open

$43.65

Previous Close

$43.87

Daily Range

$43.37 - $43.91

52-Week Range

$32.38 - $49.62

EXEL: Motley Fool Moneyball Superscore

89

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Exelixis

Industry

Biotechnology

Employees

1,077

CEO

Michael M. Morrissey, PhD

Headquarters

Alameda, CA 94502, US

EXEL Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

38%

Net Income Margin

34%

Return on Equity

36%

Return on Capital

36%

Return on Assets

28%

Earnings Yield

6.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.40B

Shares Outstanding

259.71M

Volume

55.36K

Short Interest

0.00%

Avg. Volume

2.78M

Financials (TTM)

Gross Profit

$2.24B

Operating Income

$872.19M

EBITDA

$921.76M

Operating Cash Flow

$884.27M

Capital Expenditure

$39.93M

Free Cash Flow

$844.34M

Cash & ST Invst.

$1.06B

Total Debt

$173.04M

Exelixis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$598.66M

+5.6%

Gross Profit

$572.18M

+4.6%

Gross Margin

95.58%

N/A

Market Cap

$11.40B

N/A

Market Cap/Employee

$9.94M

N/A

Employees

1,147

N/A

Net Income

$244.53M

+74.8%

EBITDA

$242.86M

+41.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$886.05M

-3.7%

Accounts Receivable

$286.92M

+8.1%

Inventory

$21.69M

-3.1%

Long Term Debt

$173.04M

-9.3%

Short Term Debt

$0.00

N/A

Return on Assets

27.51%

N/A

Return on Invested Capital

35.76%

N/A

Free Cash Flow

$332.36M

+46.9%

Operating Cash Flow

$333.51M

+38.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BMRNBioMarin Pharmaceutical Inc.
$55.50-3.04%
ALGNAlign Technology, Inc.
$170.60-1.23%
MDGLMadrigal Pharmaceuticals, Inc.
$546.89+3.22%
BBIOBridgeBio Pharma, Inc.
$73.15-1.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About EXEL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.